Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Expert Review of Pharmacoeconomics & Outcomes Research|November 22, 2011
The impact of reference-pricing systems in Europe: a literature review and case studiesPieter Dylst, Arnold Vulto, Steven SimoensHealth Policy (Amsterdam, Netherlands)|April 23, 2011
Tendering for outpatient prescription pharmaceuticals: what can be learned from current practices in Europe?Pieter Dylst, Arnold Vulto, Steven SimoensPharmacoeconomics|May 8, 2014
Barriers to the uptake of biosimilars and possible solutions: a Belgian case studyPieter Dylst, Arnold Vulto, Steven SimoensExpert Review of Pharmacoeconomics & Outcomes Research|August 7, 2014
Analysis of French generic medicines retail market: why the use of generic medicines is limitedPieter Dylst, Arnold Vulto, Steven SimoensPharmacy Practice|October 25, 2013
How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?Pieter Dylst, Arnold Vulto, Steven SimoensExpert Review of Pharmacoeconomics & Outcomes Research|February 14, 2013
Demand-side policies to encourage the use of generic medicines: an overviewPieter Dylst, Arnold Vulto, Steven SimoensExpert Review of Pharmacoeconomics & Outcomes Research|February 20, 2015
Societal value of generic medicines beyond cost-saving through reduced pricesPieter Dylst, Arnold Vulto, Steven SimoensExpert Review of Pharmacoeconomics & Outcomes Research|August 21, 2014
Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainabilityPieter Dylst, Arnold Vulto, Steven SimoensJournal of Aging & Social Policy|April 11, 2014
Does increased use of generic medicines by elders in Belgium help to contain escalating health care budgets?Pieter Dylst, Arnold Vulto, Steven SimoensApplied Health Economics and Health Policy|July 13, 2013
Generic medicines: solutions for a sustainable drug market?Pieter Dylst, Arnold Vulto, Brian Godman, et al.Pageof 3